|
1
|
Rowell JL, McCarthy DO and Alvarez CE: Dog
models of naturally occurring cancer. Trends Mol Med. 17:380–388.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Simpson RM, Bastian BC, Michael HT,
Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt
MH, Esplin DG, et al: Sporadic naturally occurring melanoma in dogs
as a preclinical model for human melanoma. Pigment Cell Melanoma
Res. 27:37–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ossio R, Roldán-Marín R, Martínez-Said H,
Adams DJ and Robles-Espinoza CD: Melanoma: A global perspective.
Nat Rev Cancer. 17:393–394. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kong Y, Si L, Zhu Y, Xu X, Corless CL,
Flaherty KT, Li L, Li H, Sheng X, Cui C, et al: Large-scale
analysis of KIT aberrations in Chinese patients with melanoma. Clin
Cancer Res. 17:1684–1691. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith SH, Goldschmidt MH and McManus PM: A
comparative review of melanocytic neoplasms. Vet Pathol.
39:651–678. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Treggiari E, Grant JP and North SM: A
retrospective review of outcome and survival following surgery and
adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant
melanoma. J Vet Med Sci. 78:845–850. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prouteau A and André C: Canine melanomas
as models for human melanomas: Clinical, histological, and genetic
comparison. Genes (Basel). 10(pii): E5012019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cancer Genome Atlas Network, . Genomic
classification of cutaneous melanoma. Cell. 161:1681–1696. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hernandez B, Adissu HA, Wei BR, Michael
HT, Merlino G and Simpson RM: Naturally occurring canine melanoma
as a predictive comparative oncology model for human mucosal and
other triple wild-type melanomas. Int J Mol Sci. 19(pii): E3942018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gillard M, Cadieu E, De Brito C, Abadie J,
Vergier B, Devauchelle P, Degorce F, Dréano S, Primot A, Dorso L,
et al: Naturally occurring melanomas in dogs as models for non-UV
pathways of human melanomas. Pigment Cell Melanoma Res. 27:90–102.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mochizuki H, Kennedy K, Shapiro SG and
Breen MB: BRAF mutations in canine cancers. PLoS One.
10:e01295342015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chu PY, Pan SL, Liu CH, Lee J, Yeh LS and
Liao AT: KIT gene exon 11 mutations in canine malignant melanoma.
Vet J. 196:226–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lindblad-Toh K, Wade CM, Mikkelsen TS,
Karlsson EK, Jaffe DB, Kamal M, Clamp M, Chang JL, Kulbokas EJ III,
Zody MC, et al: Genome sequence, comparative analysis and haplotype
structure of the domestic dog. Nature. 438:803–819. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bednarski R, Grimm K, Harvey R, Lukasik
VM, Penn WS, Sargent B and Spelts K; American Animal Hospital
Association, : AAHA anesthesia guidelines for dogs and cats. J Am
Anim Hosp Assoc. 47:377–385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoeppner MP, Lundquist A, Pirun M, Meadows
JR, Zamani N, Johnson J, Sundström G, Cook A, FitzGerald MG,
Swofford R, et al: An improved canine genome and a comprehensive
catalogue of coding genes and non-coding transcripts. PLoS One.
9:e911722014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mortazavi A, Williams BA, McCue K,
Schaeffer L and Wold B: Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods. 5:621–628. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kinsella RJ, Kähäri A, Haider S, Zamora J,
Proctor G, Spudich G, Almeida-King J, Staines D, Derwent P,
Kerhornou A, et al: Ensembl BioMarts: A hub for data retrieval
across taxonomic space. Database (Oxford). 2011:bar0302011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Vasaikar S, Shi Z, Greer M and
Zhang B: WebGestalt 2017: A more comprehensive, powerful, flexible
and interactive gene set enrichment analysis toolkit. Nucleic Acids
Res. 45((W1)): W130–W137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo W, Pant G, Bhavnasi YK, Blanchard SG
Jr and Brouwer C: Pathview Web: User friendly pathway visualization
and data integration. Nucleic Acids Res. 45((W1)): W501–W508. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43((Database Issue)): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lopes CT, Franz M, Kazi F, Donaldson SL,
Morris Q and Bader GD: Cytoscape Web: An interactive web-based
network browser. Bioinformatics. 26:2347–2348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li RW and Schroeder SG: Cytoskeleton
remodeling and alterations in smooth muscle contractility in the
bovine jejunum during nematode infection. Funct Integr Genomics.
12:35–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mi H, Muruganujan A, Casagrande JT and
Thomas PD: Large-scale gene function analysis with the PANTHER
classification system. Nat Protoc. 8:1551–1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhattacharya S, Dunn P, Thomas CG, Smith
B, Schaefer H, Chen J, Hu Z, Zalocusky KA, Shankar RD, Shen-Orr SS,
et al: ImmPort, toward repurposing of open access immunological
assay data for translational and clinical research. Sci Data.
5:1800152018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brachelente C, Cappelli K, Capomaccio S,
Porcellato I, Silvestri S, Bongiovanni L, De Maria R, Verini
Supplizi A, Mechelli L and Sforna M: Transcriptome analysis of
canine cutaneous melanoma and melanocytoma reveals a modulation of
genes regulating extracellular matrix metabolism and cell cycle.
Sci Rep. 7:63862017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Spangler WL and Kass PH: The histologic
and epidemiologic bases for prognostic considerations in canine
melanocytic neoplasia. Vet Pathol. 43:136–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miskolczi Z, Smith MP, Rowling EJ,
Ferguson J, Barriuso J and Wellbrock C: Collagen abundance controls
melanoma phenotypes through lineage-specific microenvironment
sensing. Oncogene. 37:3166–3182. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han MJ, Wang H, Beer LA, Tang HY, Herlyn M
and Speicher DW: A systems biology analysis of metastatic melanoma
using in-depth three-dimensional protein profiling. Proteomics.
10:4450–4462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tichet M, Prod'Homm V, Fenouille N,
Ambrosetti D, Mallavialle A, Cerezo M, Ohanna M, Audebert S, Rocchi
S, Giacchero D, et al: Tumour-derived SPARC drives vascular
permeability and extravasation through endothelial VCAM1 signalling
to promote metastasis. Nat Commun. 6:69932015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wurth L, Papasaikas P, Olmeda D, Bley N,
Calvo GT, Guerrero S, Cerezo-Wallis D, Martinez-Useros J,
García-Fernández M, Hüttelmaier S, et al: UNR/CSDE1 drives a
post-transcriptional program to promote melanoma invasion and
metastasis. Cancer Cell. 30:694–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Naganuma K, Hatta M, Ikebe T and Yamazaki
J: Epigenetic alterations of the keratin 13 gene in oral squamous
cell carcinoma. BMC Cancer. 14:9882014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khammanivong A, Sorenson BS, Ross KF,
Dickerson EB, Hasina R, Lingen MW and Herzberg MC: Involvement of
calprotectin (S100A8/A9) in molecular pathways associated with
HNSCC. Oncotarget. 7:14029–14047. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JH, Frantz AM, Anderson KL, Graef AJ,
Scott MC, Robinson S, Sharkey LC, O'Brien TD, Dickerson EB and
Modiano JF: Interleukin-8 promotes canine hemangiosarcoma growth by
regulating the tumor microenvironment. Exp Cell Res. 323:155–164.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Andrlová H, Mastroianni J, Madl J, Kern
JS, Melchinger W, Dierbach H, Wernet F, Follo M, Technau-Hafsi K,
Has C, et al: Biglycan expression in the melanoma microenvironment
promotes invasiveness via increased tissue stiffness inducing
integrin-β1 expression. Oncotarget. 8:42901–42916. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nagarsheth N, Wicha MS and Zou W:
Chemokines in the cancer microenvironment and their relevance in
cancer immunotherapy. Nat Rev Immunol. 17:559–572. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Labidi-Galy SI, Clauss A, Ng V, Duraisamy
S, Elias KM, Piao HY, Bilal E, Davidowitz RA, Lu Y, Badalian-Very
G, et al: Elafin drives poor outcome in high-grade serous ovarian
cancers and basal-like breast tumors. Oncogene. 34:299–309. 2015.
View Article : Google Scholar
|
|
39
|
Smedley D, Sidhar S, Birdsall S, Bennett
D, Herlyn M, Cooper C and Shipley J: Characterization of chromosome
1 abnormalities in malignant melanomas. Genes Chromosom Cancer.
28:121–125. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dracopoli NC, Harnett P, Bale SJ, Stanger
BZ, Tucker MA, Housman DE and Kefford RF: Loss of alleles from the
distal short arm of chromosome 1 occurs late in melanoma tumor
progression. Proc Natl Acad Sci USA. 86:4614–4618. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kuo PT, Zeng Z, Salim N, Mattarollo S,
Wells JW and Leggatt GR: The role of CXCR3 and its chemokine
ligands in skin disease and cancer. Front Med (Lausanne).
5:2712018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Payne AS and Cornelius LA: The role of
chemokines in melanoma tumor growth and metastasis. J Invest
Dermatol. 118:915–922. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jacquelot N, Duong CPM, Belz GT and
Zitvogel L: Targeting chemokines and chemokine receptors in
melanoma and other cancers. Front Immunol. 9:24802018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lappano R and Maggiolini M: G
protein-coupled receptors: Novel targets for drug discovery in
cancer. Nat Rev Drug Discov. 10:47–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cohen S, Levi-Montalcini R and Hamburger
V: A nerve growth-stimulating factor isolated from sarcom as 37 and
180. Proc Natl Acad Sci USA. 40:1014–1018. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Witsch E, Sela M and Yarden Y: Roles for
growth factors in cancer progression. Physiology (Bethesda).
25:85–101. 2010.PubMed/NCBI
|
|
47
|
Afratis N, Gialeli C, Nikitovic D,
Tsegenidis T, Karousou E, Theocharis AD, Pavão MS, Tzanakakis GN
and Karamanos NK: Glycosaminoglycans: Key players in cancer cell
biology and treatment. FEBS J. 279:1177–1197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang Y, van van Boxel-Dezaire AH, Cheon H,
Yang J and Stark GR: STAT3 activation in response to IL-6 is
prolonged by the binding of IL-6 receptor to EGF receptor. Proc
Natl Acad Sci USA. 110:16975–16980. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dan HC, Cooper MJ, Cogswell PC, Duncan JA,
Ting JP and Baldwin AS: Akt-dependent regulation of NF-{kappa}B is
controlled by mTOR and Raptor in association with IKK. Genes Dev.
22:1490–1500. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gentry JJ, Casaccia-Bonnefil P and Carter
BD: Nerve growth factor activation of nuclear factor kappaB through
its p75 receptor is an anti-apoptotic signal in RN22 schwannoma
cells. J Biol Chem. 275:7558–7565. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ng YP, Cheung ZH and Ip NY: STAT3 as a
downstream mediator of Trk signaling and functions. J Biol Chem.
281:15636–15644. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hendricks WPD, Zismann V, Sivaprakasam K,
Legendre C, Poorman K, Tembe W, Perdigones N, Kiefer J, Liang W,
DeLuca V, et al: Somatic inactivating PTPRJ mutations and
dysregulated pathways identified in canine malignant melanoma by
integrated comparative genomic analysis. PLoS Genet.
14:e10075892018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang D, Zhu R, Zhang H, Zheng CH and Xia
J: MGDB: A comprehensive database of genes involved in melanoma.
Database (Oxford). 2015(pii): bav0972015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bushell KR, Kim Y, Chan FC, Ben-Neriah S,
Jenks A, Alcaide M, Fornika D, Grande BM, Arthur S, Gascoyne RD, et
al: Genetic inactivation of TRAF3 in canine and human B-cell
lymphoma. Blood. 125:999–1005. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ulvé R, Rault M, Bahin M, Lagoutte L,
Abadie J, De Brito C, Coindre JM, Botherel N, Rousseau A, Wucher V,
et al: Discovery of human-similar gene fusions in canine cancers.
Cancer Res. 77:5721–5727. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li Z, Ivanov AA, Su R, Gonzalez-Pecchi V,
Qi Q, Liu S, Webber P, McMillan E, Rusnak L, Pham C, et al: The
OncoPPi network of cancer-focused protein-protein interactions to
inform biological insights and therapeutic strategies. Nat Commun.
8:143562017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hamidi H, Pietilä M and Ivaska J: The
complexity of integrins in cancer and new scopes for therapeutic
targeting. Br J Cancer. 115:1017–1023. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen P, Cescon M and Bonaldo P: Collagen
VI in cancer and its biological mechanisms. Trends Mol Med.
19:410–417. 2013. View Article : Google Scholar : PubMed/NCBI
|
